オーストラリアの股関節再建市場動向(~2021)

◆英語タイトル:Australia Hip Reconstruction Market Outlook to 2021
◆商品コード:GDMECC1118DB
◆発行会社(リサーチ会社):GlobalData
◆発行日:2015年8月7日
◆ページ数:43
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:オーストラリア
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥550,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD7,500 ⇒換算¥825,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Australia Hip Reconstruction Market Outlook to 2021

Summary

GlobalData’s new report, “Australia Hip Reconstruction Market Outlook to 2021″, provides key market data on the Australia Hip Reconstruction market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market segments – Primary Hip Replacement, Partial Hip Replacement, Revision Hip Replacement and Hip Resurfacing.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size for Hip Reconstruction market segments – Primary Hip Replacement, Partial Hip Replacement, Revision Hip Replacement and Hip Resurfacing.
- Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for Hip Reconstruction market.
- Global corporate-level profiles of key companies operating within the Australia Hip Reconstruction market.
- Key players covered include Zimmer Holdings, Inc., Stryker Corporation, DePuy Companies, Smith & Nephew Plc, Biomet, Inc. and Wright Medical Group, Inc.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

【レポートの目次】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4
2 Introduction 5
2.1 What Is This Report About? 5
2.2 Hip Reconstruction Market Segmentation 5
2.3 Definitions of Markets Covered in the Report 6
3 Hip Reconstruction Market, Australia 7
3.1 Hip Reconstruction Market, Australia, Revenue ($m), 2007-2014 7
3.2 Hip Reconstruction Market, Australia, Revenue ($m), 2014-2021 9
3.2.1 Primary Hip Replacement Market, Australia, Revenue ($m), by Segment, 2007-2014 11
3.2.2 Primary Hip Replacement Market, Australia, Revenue ($m), by Segment, 2014-2021 13
3.3 Hip Reconstruction Market, Australia, Volume (Units), 2007-2014 15
3.4 Hip Reconstruction Market, Australia, Volume (Units), 2014-2021 17
3.4.1 Primary Hip Replacement Market, Australia, Volume (Units), by Segment, 2007-2014 19
3.4.2 Primary Hip Replacement Market, Australia, Volume (Units), by Segment, 2014-2021 21
3.5 Hip Reconstruction Market, Australia, Average Price ($), 2007-2021 23
3.6 Hip Reconstruction Market, Australia, Distribution Share by Revenue ($m), 2013-2014 25
3.7 Hip Reconstruction Market, Australia, Company Share by Revenue ($m), 2014 26
4 Overview of Key Companies in Australia, Hip Reconstruction Market 28
4.1 Zimmer Biomet Holdings, Inc. 28
4.1.1 Company Overview 28
4.2 DePuy Companies 28
4.2.1 Company Overview 28
4.3 Smith & Nephew Plc 28
4.3.1 Company Overview 28
4.4 Stryker Corporation 29
4.4.1 Company Overview 29
4.5 Biomet, Inc. (Inactive) 29
4.5.1 Company Overview 29
4.6 Corin Group Plc 29
4.6.1 Company Overview 29
4.7 Tornier N.V. 30
4.7.1 Company Overview 30
5 Hip Reconstruction Market Pipeline Products 31
6 Financial Deals Landscape 32
6.1 Partnerships 32
6.1.1 DePuy Synthes Enters into Agreement with Radlink 32
7 Recent Developments 33
7.1 Corporate Communications 33
7.1.1 Aug 06, 2014: Global Appoints New Board Member 33
7.2 Financial Announcements 33
7.2.1 Apr 15, 2015: Cara Therapeutics to Present at 3rd Conference on the Therapeutic Potential of Kappa Opioids 33
8 Appendix 35
8.1 Research Methodology 36
8.1.1 Coverage 36
8.1.2 Secondary Research 36
8.1.3 Primary Research 37
8.1.4 Market Modeling and Forecasting 38
8.1.5 Company Share Analysis 41
8.1.6 Distribution Share Analysis 42
8.2 Expert Panel 43
8.3 GlobalData Consulting 43
8.4 Contact Us 43
8.5 Disclaimer 43

1.1 List of Tables
Table 1: Hip Reconstruction Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 8
Table 2: Hip Reconstruction Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 10
Table 3: Primary Hip Replacement Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 12
Table 4: Primary Hip Replacement Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 14
Table 5: Hip Reconstruction Market, Australia, Volume (Units), Historic, 2007-2014 16
Table 6: Hip Reconstruction Market, Australia, Volume (Units), Forecast, 2014-2021 18
Table 7: Primary Hip Replacement Market, Australia, Volume (Units), Historic, 2007-2014 20
Table 8: Primary Hip Replacement Market, Australia, Volume (Units), Forecast, 2014-2021 22
Table 9: Hip Reconstruction Market, Australia, Average Price ($), Historic, 2007-2014 23
Table 10: Hip Reconstruction Market, Australia, Average Price ($), Forecast, 2014-2021 24
Table 11: Hip Reconstruction Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2013-2014 25
Table 12: Hip Reconstruction Market, Australia, Company Share by Revenue ($m), USD Constant2014 27
Table 13: Hip Reconstruction Market Pipeline Products 31
Table 14: DePuy Synthes Enters into Agreement with Radlink 32
Table 15: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country 38

1.2 List of Figures
Figure 1: Hip Reconstruction Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 7
Figure 2: Hip Reconstruction Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 9
Figure 3: Primary Hip Replacement Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 11
Figure 4: Primary Hip Replacement Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 13
Figure 5: Hip Reconstruction Market, Australia, Volume (Units), Historic, 2007-2014 15
Figure 6: Hip Reconstruction Market, Australia, Volume (Units), Forecast, 2014-2021 17
Figure 7: Primary Hip Replacement Market, Australia, Volume (Units), Historic, 2007-2014 19
Figure 8: Primary Hip Replacement Market, Australia, Volume (Units), Forecast, 2014-2021 21
Figure 9: Hip Reconstruction Market, Australia, Company Share (%) 2014 26
Figure 10: GlobalData Epidemiology-Based Forecasting Model 40
Figure 11: GlobalData Capital Equipment-Based Forecasting Model 41
Figure 12: Primary Interviews by Participant Type (%) 42

【掲載企業】

Zimmer Biomet Holdings, Inc.
DePuy Companies
Smith & Nephew Plc
Stryker Corporation
Corin Group Plc
Tornier N.V.

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ オーストラリアの股関節再建市場動向(~2021)(Australia Hip Reconstruction Market Outlook to 2021)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆